Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Tata in Talks to Buy Wistron’s India Facility for up to $613M

https://economictimes.indiatimes.com/news/india/tata-eyes-apple-vendor-wistrons-facility-in-karnataka/articleshow/95867346.cms
byCharles Gross
November 30, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://economictimes.indiatimes.com/news/india/tata-eyes-apple-vendor-wistrons-facility-in-karnataka/articleshow/95867346.cms

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AbbVie Announced Provincial Reimbursement for RINVOQ® (upadacitinib) for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis in Alberta, New Brunswick, Ontario, Quebec and Saskatchewan

By Charles Gross
December 1, 8:06 AM
AbbVie (NYSE: ABBV), today announced that RINVOQ is now listed as a special authorization medication or exception medication status on the formularies of Alberta1, New Brunswick2, Ontario3, Quebec4 and Saskatchewan5 for the treatment of adults with rheumatoid arthritis (RA) and psoriatic arthritis (PsA).

ABBV